Vext Science
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vext Science generated cash of $4,424,704, which is less than the previous year. Cash used in financing activities reached the amount of $3,185,590 last year. Net change in cash is therefore $2,786,292.
Cash Flow
| 2017 | 4.10M | -1.13M | -1.06M |
|---|---|---|---|
| 2018 | 3.74M | -1.42M | 2.58M |
| 2019 | -393.31K | -5.40M | 9.69M |
| 2020 | 3.09M | -12.90M | 4.25M |
| 2021 | 11.68M | -27.09M | 20.13M |
| 2022 | 5.92M | -30.31M | 23.85M |
| 2023 | 4.42M | -4.82M | 3.18M |
VEXTF Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.93M | 6.46M | 1.74M | 7.29M | 3.39M | 0 | 0 |
Operating activities | |||||||
Net income | 4.39M | 10.91M | 4.98M | 2.12M | 2.79M | 3.74M | 4.10M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 9.59M | 6.43M | 3.28M | 2.13M | 833.25K | 0 | 414.17K |
Stock-based compensation expense | 384.61K | 1.45M | 949.66K | 879.67K | 419.55K | 0 | 0 |
| Deferred income tax benefit | 384.61K | 1.45M | 949.66K | 879.67K | 419.55K | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 1.43M | -1.24M | -4.66M | -1.67M | -5.27M | 0 | -4.28M |
Inventories | 2.50M | -5.67M | 642.45K | -857.31K | 73.97K | 0 | -31.75K |
Accounts payable | 0 | 210.98K | 450.75K | 723.85K | 373.90K | 0 | 0 |
Cash generated by operating activities | 4.42M | 5.92M | 11.68M | 3.09M | -393.31K | 3.74M | 4.10M |
Investing activities | |||||||
Purchases Of Investments | 0 | -658.04K | -97.83K | -180.52K | -150.41K | 0 | 0 |
Investments In Property Plant And Equipment | -2.73M | -8.86M | -18.78M | -4.06M | -5.25M | -1.50M | -1.13M |
Acquisitions Net | -6.61M | -8.51M | -2.73M | -2.93M | -147K | 79.52K | 0 |
Cash generated by investing activities | -4.82M | -30.31M | -27.09M | -12.90M | -5.40M | -1.42M | -1.13M |
Financing activities | |||||||
Common Stock Issued | 16.34M | 124.7K | 18.43M | 5.50M | 5.15M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -8.44M | 23.72M | -893.95K | -684.34K | 5.22M | 0 | -748.68K |
Cash used in financing activities | 3.18M | 23.85M | 20.13M | 4.25M | 9.69M | 2.58M | -1.06M |
Net Change In Cash | 2.78M | -533.25K | 4.72M | -5.54M | 3.89M | 4.90M | 1.90M |
Cash at end of period | 8.72M | 5.93M | 6.46M | 1.74M | 7.29M | 4.90M | 1.90M |